HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hypochlorhydria and achlorhydria are associated with false-positive secretin stimulation testing for Zollinger-Ellison syndrome.

AbstractOBJECTIVES:
Secretin stimulation testing (SST) is used to evaluate patients with hypergastrinemia in the diagnosis of Zollinger-Ellison syndrome. Case series have documented false-positive SST in patients with achlorhydria. This study reviews our experience with SST in hypochlorhydric and achlorhydric patients.
METHODS:
We examined 27 patients with hypochlorhydria or achlorhydria based on a predefined basal acid output (BAO) measurement of less than 5.0 mEq/h who also underwent SST for diagnosis of Zollinger-Ellison syndrome. We report the frequency of false-positive SST results in this setting.
RESULTS:
Three hundred thirty patients underwent gastric analysis of which 27 had BAO of less than 5.0 mEq/h and SST conducted. The mean (SD) fasting gastrin level was 247 (304) pg/mL, and the mean (SD) BAO measurement was 1.6 (1.8) mEq/h. Twenty patients were off, and 7 were on antisecretory therapy at time of testing. Four patients had false-positive SST results: 3 with gastric atrophy (BAO = 0 mEq/h) and 1 with drug-induced hypochlorhydria (BAO = 0.5 mEq/hr). These false-positive test results were confirmed by structural and functional imaging studies.
CONCLUSIONS:
We have identified a 14.8% false-positive rate in SST in patients with hypochlorhydria or achlorhydria. Growing literature has identified severe consequences associated with discontinuing antisecretory treatment for testing; therefore, SST will require interpretation in the setting of gastric acid suppression and needs to be interpreted in this context.
AuthorsPari Shah, Maneesh H Singh, Yu-Xiao Yang, David C Metz
JournalPancreas (Pancreas) Vol. 42 Issue 6 Pg. 932-6 (Aug 2013) ISSN: 1536-4828 [Electronic] United States
PMID23851430 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Anti-Ulcer Agents
  • Lansoprazole
  • Secretin
  • Rabeprazole
  • Omeprazole
  • Esomeprazole
Topics
  • Achlorhydria (complications, metabolism)
  • Adolescent
  • Adult
  • Aged
  • Anti-Ulcer Agents (pharmacology)
  • Esomeprazole (pharmacology)
  • False Positive Reactions
  • Female
  • Gastric Acid (metabolism)
  • Gastric Mucosa (metabolism)
  • Humans
  • Lansoprazole (pharmacology)
  • Male
  • Middle Aged
  • Omeprazole (pharmacology)
  • Rabeprazole (pharmacology)
  • Secretin
  • Sensitivity and Specificity
  • Stomach (drug effects, pathology)
  • Young Adult
  • Zollinger-Ellison Syndrome (complications, diagnosis, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: